Altai Protocol Library New Reference: Enzalutamide in Biochemically Recurrent Prostate Cancer U. Darda Bayraktar, MD 2025-11-12
Altai Protocol Library New Reference: Revumenib for Rel/Ref KMT2A-Rearranged AML U. Darda Bayraktar, MD 2025-11-06
Altai Protocol Library New Reference: Belantamab for Multiple Myeloma U. Darda Bayraktar, MD 2025-11-06
Altai Protocol Library New Indication: Revumenib for Rel/Ref NPM1-Mutated AML U. Darda Bayraktar, MD 2025-10-26
Altai Protocol Library New Drug: Zanzalintinib for Metastatic Colorectal Cancer U. Darda Bayraktar, MD 2025-10-26
Altai Protocol Library New Indication: Quizartinib for Newly Diagnosed AML (FLT3-ITD Negative) U. Darda Bayraktar, MD 2025-10-23
Altai Protocol Library New Reference: Rituximab – Ibrutinib for Untreated Mantle Cell Lymphoma U. Darda Bayraktar, MD 2025-10-23
Altai Protocol Library New Reference: Neoadjuvant FOLFIRINOX vs. Chemoradiation for Pancreatic Cancer U. Darda Bayraktar, MD 2025-10-22
Altai Protocol Library New Indication: Lenvatinib + Pembrolizumab for Thymic Carcinoma U. Darda Bayraktar, MD 2025-10-22
Altai Protocol Library New Reference: Osimertinib with Platinum-Pemetrexed for Advanced EGFR-Mutated NSCLC U. Darda Bayraktar, MD 2025-10-21
